Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scopolamine effects on attention in healthy adult men
ACTRN12611000603910Phase 4Not yet recruiting
- Sponsor
- The University of Queensland
- Start
- Jun 2011
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of scopolamine (2 arms), sponsored by The University of Queensland. Primary endpoints: Attentional processing measured using an EEF paradigm quantifying Steady State Visual Evoked Potentials and Spatial attention using a Contingent Capture task. Planned start Jun 2011; status: not yet recruiting.
02
Drugs
scopolamine
Beyond the preview
Go deeper on ACTRN12611000603910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000603910.